|
Real-time Estimate
Cboe BZX
10:51:29 17/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.075 USD | +0.47% |
|
-4.87% | -35.63% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
NYSE
LCTX 1.070 $
0.00%
3L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| LCTX | 1.070USD | 0.00% | 3L $ | |
CBOE
| LCTX | 1.070USD | -0.47% | 5.9T $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 325.90ILa | -0.91% | 4L ILa | |
|
Tradegate
| BT3 | 0.8930EUR | -3.98% | 11.61 € | |
|
Deutsche Boerse AG
| BT3 | 0.8940EUR | +0.45% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9110EUR | -0.22% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9360EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.2 | 1.35 | 1.35 |
| Spread/Res. | -10.42% | -20.37% | -20.37% |
| Spread/Supp. | +4.37% | +4.37% | +4.37% |
| Support | 1.03 | 1.03 | 1.03 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
